We also analyzed changes in the MGMT methylation level and Ki67 and p53 tumor protein levels in their dependence on clinical characteristics of GBMPs (age, sex, relapse status, progression pattern, and residual tumor volume according to the MRI data) (Table 3, Table 4 and Table 5). This evidence concerns the gene TP53 and neoplasm.